Whitehawk Therapeutics
WHWK
41 hedge funds and large institutions have $54.3M invested in Whitehawk Therapeutics in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
5% more funds holding
Funds holding: 39 → 41 (+2)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
0% less capital invested
Capital invested by funds: $54.6M → $54.3M (-$268K)
1.3% less ownership
Funds ownership: 62.48% → 61.18% (-1.3%)
50% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Stempoint Capital
New York
|
+$780K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$205K |
| 3 |
PLC
Peapod Lane Capital
Bedford Hills,
New York
|
+$113K |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$64.8K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$50.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$2.04M |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$184K |
| 3 |
Jane Street
New York
|
-$147K |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$49K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$37K |
WHWK Hedge Fund Activity: Q3 2025 in Review
41 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Whitehawk Therapeutics (WHWK) for Q3 2025, worth a combined $54.3M — down 0.49% from $54.6M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new WHWK positions and 3 closed out — a net gain of 2 holders — while 5 added to existing stakes and 10 trimmed.
The largest buyer was Stempoint Capital, opening a new position worth an estimated $780K. The largest seller was EcoR1 Capital, exiting entirely with an estimated $2.04M sold.
- 41 institutional investors held Whitehawk Therapeutics (WHWK) as of Q3 2025, up from 39 in Q2 2025.
- Funds reported $54.3M of Whitehawk Therapeutics stock for Q3 2025, down 0.49% quarter-over-quarter.
- 5 funds opened new Whitehawk Therapeutics positions in Q3 2025 and 3 closed out, a net change of +2 holders.
- The largest Whitehawk Therapeutics buyer in Q3 2025 was Stempoint Capital, an estimated $780K added.
- The largest Whitehawk Therapeutics seller in Q3 2025 was EcoR1 Capital, an estimated $2.04M sold.
Based on aggregated 13F filings for Q3 2025.